Table 2.

The calculated stability constants and the achieved solubility enhancement based on phase solubility study.

Cyclodextrin	K (mean ± SD, n = 3)	Maximum solubility enhancement (CD concentration)
α-	2.7 ± 0.5	1.10 × (30mM)
β-	97.2 ± 3.1	2.16 × (11.8 mM)
γ-	30.3 ± 0.8	1.70 × (30 mM)
HP-β- DS 3	68.5 ± 1.1	3.27 × (30 mM)
HP-β- DS 4.5	129.9 ± 2.2	4.66 × (30 mM)
HP-β- DS 6	87.7 ± 2.8	3.69 × (30 mM)
RAMEB	101.7 ± 1.7	3.75 × (30mM)
TRIMEB	24.0 ± 0.6	1.74 × (30mM)
SBE-β-CD DS 7	194.6 ± 1.0	6.93 × (30mM)